Michael F. Huang Soleno Therapeutics Inc (SLNO) insider trading activity
Michael F. Huang is Sr. VP of Clinical Development of SOLENO THERAPEUTICS INC. Currently has a direct ownership of 35,000 shares of SLNO, which is worth approximately $1.68 Million. The most recent transaction as insider was on Jul 17, 2024, when has been sold 35,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
35K
0%
3M change
n/a
12M change
Total Value Held
$1.68 Million
MFH
Michael F. Huang
Sr. VP of Clinical Development
Redwood City, CA